Myocardial ischemia--metabolic pathways and implications of increased glycolysis

Cardiovascular Drugs and Therapy
L H Opie

Abstract

Evidence is reviewed that favors the hypothesis that maintenance of glycolysis plays a special role in protecting membrane function in ischemia. Therefore all procedures stimulating glycolytic flux should be beneficial in ischemia, and procedures inhibiting flux should be harmful. However, a crucial consideration is the coronary flow rate. In severe ischemia, accumulation of protons, derived not directly from glycolytic flux but from the breakdown of ATP and from proton-producing cycles, will tend to inhibit glycolysis and to minimize any benefit from increased glycolytic flux. Therefore maintenance of intracellular pH is crucial to the concept of the benefits of glycolysis. It also follows that the severity of ischemia can determine whether or not enhanced glycolysis has a beneficial effect. It is argued that a multiple approach, including enhanced glycolytic flux, control of intracellular pH, and improved coronary flow, constitutes the combination most likely to benefit ischemia.

References

Oct 1, 1991·Cardiovascular Drugs and Therapy·M B Forman, C E Velasco
Mar 1, 1991·Cardiovascular Drugs and Therapy·L H Opie
Jul 1, 1996·European Journal of Nuclear Medicine·G Hör
Mar 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·H Schelbert
Aug 24, 1995·The American Journal of Cardiology·C Knight, K Fox
Aug 24, 1995·The American Journal of Cardiology·L H Opie, F Boucher
Apr 11, 2001·Mechanisms of Ageing and Development·R P DillW S Parkhouse
Dec 2, 1999·Mechanisms of Ageing and Development·L C MartineauW S Parkhouse
Dec 19, 2000·Free Radical Biology & Medicine·D R Janero, J F Ewing
Jan 15, 2013·Antioxidants & Redox Signaling·Michele UmbrelloMervyn Singer
Nov 26, 2010·Cardiovascular Research·Christian F Rueda-ClausenSandra T Davidge
Oct 10, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Oliver J Rider, Damian J Tyler
Dec 2, 1992·Molecular and Cellular Biochemistry·M J de GrootG J van der Vusse
Sep 24, 2004·Diabetes/metabolism Research and Reviews·Tom L BroderickMelissa Gillis
Jul 4, 2012·Molecular and Cellular Endocrinology·Jeevan NagendranJason R B Dyck
Aug 11, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Heike WankaJörg Peters
Jun 20, 2008·Proteomics·Justyna Fert-BoberGrzegorz Sawicki
Dec 1, 2012·Molecular Nutrition & Food Research·Émilie C Lefort, Jonathan Blay
Feb 13, 2002·Seminars in Nuclear Medicine·H Schelbert
Aug 12, 2009·Basic & Clinical Pharmacology & Toxicology·Edgars LiepinshMaija Dambrova
Nov 1, 1995·The Annals of Thoracic Surgery·E F HoffenbergR Deslauriers
Dec 1, 1994·The Annals of Thoracic Surgery·R F StahlT J Vander Salm
Oct 27, 2010·Journal of Molecular and Cellular Cardiology·Fatima MraicheLarry Fliegel
Nov 24, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Junhwan KimLance B Becker
Jul 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·A E Schussheim, G K Radda
Jun 13, 2019·Journal of the American Heart Association·Diem H Tran, Zhao V Wang
May 9, 2020·Journal of Cellular and Molecular Medicine·Coert J ZuurbierThomas Krieg
Oct 23, 2002·Journal of Applied Physiology·Mirit EynanMichal Horowitz
Jan 1, 1994·The American Journal of Physiology·D R JaneroH M Sharif
May 12, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Clifford D L FolmesG D Lopaschuk

Citations

Jun 1, 1978·Journal of Molecular and Cellular Cardiology·P A Poole-Wilson
Apr 28, 1978·Annals of the New York Academy of Sciences·A L LehningerW P Tew
Dec 15, 1979·The Biochemical Journal·P B GarlickP J Seeley
Oct 28, 1978·Lancet·L H OpieW F Lubbe
Jan 1, 1977·Current Topics in Cellular Regulation·J H Ottaway, J Mowbray
Jan 1, 1976·Reviews of Physiology, Biochemistry and Pharmacology·E Hofmann
Sep 1, 1975·Journal of Molecular and Cellular Cardiology·J M ChesnaisJ M Vassas
Mar 1, 1978·Journal of Molecular and Cellular Cardiology·B C Sinclair-Smith, L H Opie
Nov 1, 1977·Journal of Molecular and Cellular Cardiology·W Gevers
Jun 1, 1977·The American Journal of Cardiology·D J HearseS M Humphrey
Jul 1, 1976·Journal of Molecular and Cellular Cardiology·J R SerurP J Laraia
Jan 1, 1976·Circulation·T N James
Aug 1, 1990·Cardiovascular Drugs and Therapy·A RossiJ Martin
Apr 1, 1990·Cardiovascular Drugs and Therapy·A CherchiM Corsi
Jun 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M KohlhardtU Fröbe
Jan 1, 1988·Cardiovascular Drugs and Therapy·W A Coetzee
May 1, 1986·The American Journal of Physiology·D P Jones
Sep 1, 1988·Circulation Research·E MarbanM M Pike
Mar 1, 1988·Cardiovascular Drugs and Therapy·J F Renaud
Jul 1, 1987·American Heart Journal·L F SatlerC E Rackley
Apr 3, 1986·The New England Journal of Medicine·J TillischH Schelbert

Related Concepts

Ischemia
Membrane by Function
Lactate
Protoplasm
Myocardium
Glucose, (beta-D)-Isomer
NADH
Myocardial Ischemia
Protons
Ammonium lactate

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

© 2020 Meta ULC. All rights reserved